Advertisement
Screener

VERICEL CORPORATION (VCEL) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

VERICEL CORPORATION Basic Shares Outstanding (Weighted Average)

VERICEL CORPORATION (VCEL) reported Basic Shares Outstanding (Weighted Average) of 51.08 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30

  • VERICEL CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 51.08M shares, a 1.40% increase year-over-year.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 50.77M shares, a 1.74% increase year-over-year.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 50.59M shares, a 2.26% increase year-over-year.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 50.49M shares, a 2.86% increase year-over-year.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for fiscal 2025 was 50.34M shares, a 3.05% increase from fiscal 2024.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for fiscal 2024 was 48.85M shares, a 2.64% increase from fiscal 2023.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for fiscal 2023 was 47.59M shares, a 0.98% increase from fiscal 2022.
  • VERICEL CORPORATION weighted average number of shares outstanding, basic for fiscal 2022 was 47.13M shares, a 1.42% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 12 month
2026-06-3051.08M shares
10-Q · filed 2026-07-30
50.92M shares
10-Q · filed 2026-07-30
50.81M shares
derived: average of 3 quarters · filed 2026-07-30
50.73M shares
derived: average of 4 quarters · filed 2026-07-30
2026-03-3150.77M shares
10-Q · filed 2026-05-07
50.68M shares
derived: average of 2 quarters · filed 2026-05-07
50.62M shares
derived: average of 3 quarters · filed 2026-05-07
50.56M shares
derived: average of 4 quarters · filed 2026-07-30
2025-12-3150.59M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
50.54M shares
derived: average of 2 quarters · filed 2026-02-26
50.48M shares
derived: average of 3 quarters · filed 2026-07-30
50.34M shares
10-K · filed 2026-02-26
2025-09-3050.49M shares
10-Q · filed 2025-11-06
50.43M shares
derived: average of 2 quarters · filed 2026-07-30
50.26M shares
10-Q · filed 2025-11-06
50.06M shares
derived: average of 4 quarters · filed 2026-07-30
2025-06-3050.37M shares
10-Q · filed 2026-07-30
50.14M shares
10-Q · filed 2026-07-30
49.92M shares
derived: average of 3 quarters · filed 2026-07-30
49.71M shares
derived: average of 4 quarters · filed 2026-07-30
2025-03-3149.91M shares
10-Q · filed 2026-05-07
49.69M shares
derived: average of 2 quarters · filed 2026-05-07
49.49M shares
derived: average of 3 quarters · filed 2026-05-07
49.29M shares
derived: average of 4 quarters · filed 2026-05-07
2024-12-3149.48M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
49.28M shares
derived: average of 2 quarters · filed 2026-02-26
49.08M shares
derived: average of 3 quarters · filed 2026-02-26
48.85M shares
10-K · filed 2026-02-26
2024-09-3049.09M shares
10-Q · filed 2025-11-06
48.89M shares
derived: average of 2 quarters · filed 2025-11-06
48.64M shares
10-Q · filed 2025-11-06
48.42M shares
derived: average of 4 quarters · filed 2026-02-26
2024-06-3048.69M shares
10-Q · filed 2025-07-31
48.41M shares
10-Q · filed 2025-07-31
48.19M shares
derived: average of 3 quarters · filed 2026-02-26
48.06M shares
derived: average of 4 quarters · filed 2026-02-26
2024-03-3148.14M shares
10-Q · filed 2025-05-08
47.95M shares
derived: average of 2 quarters · filed 2026-02-26
47.85M shares
derived: average of 3 quarters · filed 2026-02-26
47.78M shares
derived: average of 4 quarters · filed 2026-02-26
2023-12-3147.75M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
47.70M shares
derived: average of 2 quarters · filed 2026-02-26
47.66M shares
derived: average of 3 quarters · filed 2026-02-26
47.59M shares
10-K · filed 2026-02-26
2023-09-3047.65M shares
10-Q · filed 2024-11-07
47.61M shares
derived: average of 2 quarters · filed 2024-11-07
47.54M shares
10-Q · filed 2024-11-07
47.46M shares
derived: average of 4 quarters · filed 2025-02-27
2023-06-3047.57M shares
10-Q · filed 2024-08-01
47.48M shares
10-Q · filed 2024-08-01
47.40M shares
derived: average of 3 quarters · filed 2025-02-27
47.34M shares
derived: average of 4 quarters · filed 2025-02-27
2023-03-3147.39M shares
10-Q · filed 2024-05-08
47.31M shares
derived: average of 2 quarters · filed 2025-02-27
47.27M shares
derived: average of 3 quarters · filed 2025-02-27
47.23M shares
derived: average of 4 quarters · filed 2025-02-27
2022-12-3147.23M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
47.21M shares
derived: average of 2 quarters · filed 2025-02-27
47.18M shares
derived: average of 3 quarters · filed 2025-02-27
47.13M shares
10-K · filed 2025-02-27
2022-09-3047.18M shares
10-Q · filed 2023-11-08
47.15M shares
derived: average of 2 quarters · filed 2023-11-08
47.10M shares
10-Q · filed 2023-11-08
47.03M shares
derived: average of 4 quarters · filed 2024-02-29
2022-06-3047.12M shares
10-Q · filed 2023-08-02
47.05M shares
10-Q · filed 2023-08-02
46.98M shares
derived: average of 3 quarters · filed 2024-02-29
46.90M shares
derived: average of 4 quarters · filed 2024-02-29
2022-03-3146.98M shares
10-Q · filed 2023-05-10
46.90M shares
derived: average of 2 quarters · filed 2024-02-29
46.83M shares
derived: average of 3 quarters · filed 2024-02-29
46.72M shares
derived: average of 4 quarters · filed 2024-02-29
2021-12-3146.82M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
46.75M shares
derived: average of 2 quarters · filed 2024-02-29
46.63M shares
derived: average of 3 quarters · filed 2024-02-29
46.47M shares
10-K · filed 2024-02-29
2021-09-3046.67M shares
10-Q · filed 2022-11-09
46.54M shares
derived: average of 2 quarters · filed 2022-11-09
46.35M shares
10-Q · filed 2022-11-09
46.15M shares
derived: average of 4 quarters · filed 2023-02-23
2021-06-3046.40M shares
10-Q · filed 2022-08-03
46.20M shares
10-Q · filed 2022-08-03
45.98M shares
derived: average of 3 quarters · filed 2023-02-23
45.80M shares
derived: average of 4 quarters · filed 2023-02-23
2021-03-3145.98M shares
10-Q · filed 2022-05-04
45.77M shares
derived: average of 2 quarters · filed 2023-02-23
45.60M shares
derived: average of 3 quarters · filed 2023-02-23
45.49M shares
derived: average of 4 quarters · filed 2023-02-23
2020-12-3145.55M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
45.41M shares
derived: average of 2 quarters · filed 2023-02-23
45.32M shares
derived: average of 3 quarters · filed 2023-02-23
45.22M shares
10-K · filed 2023-02-23
2020-09-3045.27M shares
10-Q · filed 2021-11-09
45.20M shares
derived: average of 2 quarters · filed 2021-11-09
45.11M shares
10-Q · filed 2021-11-09
45.03M shares
derived: average of 4 quarters · filed 2022-02-24
2020-06-3045.14M shares
10-Q · filed 2021-08-04
45.03M shares
10-Q · filed 2021-08-04
44.95M shares
derived: average of 3 quarters · filed 2022-02-24
44.77M shares
derived: average of 4 quarters · filed 2022-02-24
2020-03-3144.92M shares
10-Q · filed 2021-05-05
44.85M shares
derived: average of 2 quarters · filed 2022-02-24
44.65M shares
derived: average of 3 quarters · filed 2022-02-24
2019-12-3144.78M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
44.52M shares
derived: average of 2 quarters · filed 2022-02-24
44.18M shares
10-K · filed 2022-02-24
2019-09-3044.25M shares
10-Q · filed 2020-11-05
43.98M shares
10-Q · filed 2020-11-05
2018-12-3143.48M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
43.20M shares
derived: average of 2 quarters · filed 2021-02-24
40.24M shares
10-K · filed 2021-02-24
2018-09-3042.92M shares
10-Q · filed 2019-11-05
39.16M shares
10-Q · filed 2019-11-05
2012-03-3138.74M shares
10-Q · filed 2012-05-10
38.69M shares
derived: average of 2 quarters · filed 2012-05-10
38.67M shares
derived: average of 3 quarters · filed 2012-05-10
38.66M shares
derived: average of 4 quarters · filed 2012-05-10
2011-12-3138.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15
38.63M shares
derived: average of 2 quarters · filed 2012-03-15
38.63M shares
derived: average of 3 quarters · filed 2012-03-15
38.63M shares
10-K · filed 2012-03-15
2011-09-3038.63M shares
10-Q · filed 2011-11-08
38.63M shares
derived: average of 2 quarters · filed 2011-11-08
38.62M shares
10-Q · filed 2011-11-08
36.50M shares
derived: average of 4 quarters · filed 2012-05-10
2011-06-3038.62M shares
10-Q · filed 2011-08-15
38.62M shares
10-Q · filed 2011-08-15
35.79M shares
derived: average of 3 quarters · filed 2012-05-10
33.90M shares
derived: average of 4 quarters · filed 2012-05-10
2011-03-3138.62M shares
10-Q · filed 2012-05-10
34.37M shares
derived: average of 2 quarters · filed 2012-05-10
32.33M shares
derived: average of 3 quarters · filed 2012-05-10
31.31M shares
derived: average of 4 quarters · filed 2012-05-10
2010-12-3130.12M shares
derived: 10-K 6 month − 10-Q 3 month · filed 2012-03-15
29.19M shares
10-K · filed 2012-03-15
28.88M shares
derived: average of 3 quarters · filed 2012-03-15
2010-09-3028.25M shares
10-Q · filed 2011-11-08
28.26M shares
derived: average of 2 quarters · filed 2011-11-08
27.75M shares
10-Q · filed 2011-11-08
2010-06-3028.26M shares
10-Q · filed 2011-08-15
27.50M shares
10-Q · filed 2011-08-15
24.73M shares
10-K · filed 2012-03-15
2009-06-3017.88M shares
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80